Skip to main content
Premium Trial:

Request an Annual Quote

Not Quite Sent

The US likely won't to meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month due to regulatory and other requirements, the Washington Post reports.

Last month, President Joe Biden announced that the US would be sharing, in addition to the already promised 60 million doses of the AstraZeneca vaccine, 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines. The US said it would be working with COVAX, the international vaccine effort, to distribute most of those vaccines.

But as the Post now reports, fewer than 10 million doses – mostly to Mexico, Canada, South Korea, and Taiwan – have been shipped. The holdup, it adds, is largely due to the legal, logistical, and regulatory requirements of both the US and recipient countries.

As the Hill notes, the Biden Administration has further announced it is allocating an additional 55 million doses to send abroad, 41 million of which will be distributed through COVAX to countries in Latin America, Asia, and Africa, and 14 million of which will be sent directly to countries including Colombia, Argentina, Haiti, Afghanistan, Pakistan, and Iraq.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.